ABUS vs AWK
Arbutus Biopharma Corp (ABUS) versus American Water Works (AWK) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
American Water Works (AWK) is a utilities - regulated water company listed on US.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported AWK revenue for 2024-12-31 was $4.65B. Net income was $239.0M. Revenue was up 10.3% from 2023-12-31 to 2024-12-31. AWK currently screens at market cap $24.31B and trailing P/E 22.1.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. AWK currently screens at market cap $24.31B and trailing P/E 22.1.
Not investment advice. Open the ABUS and AWK stock pages for the full models.
Not investment advice.